Related Experiment Video
Updated: May 10, 2026

08:52
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
A case report of osteogenic sarcoma with leprosy
Jyoti Bajpai1, Nishitha Shetty, Alok Gupta
1Department of Medical Oncology, Tata Memorial Hospital, Mumbai, India.
Journal of Cancer Research and Therapeutics
|June 18, 2013
Summary
A rare case report details a 15-year-old male with osteosarcoma who developed leprosy after chemotherapy. Prompt diagnosis and treatment of both conditions led to full recovery of skin lesions.
Area of Science:
- Oncology
- Infectious Diseases
- Dermatology
Background:
- Osteosarcoma is a primary malignant bone tumor, often affecting adolescents and young adults.
- Leprosy, a chronic infectious disease caused by Mycobacterium leprae, primarily affects the skin, peripheral nerves, and upper respiratory tract.
- The co-occurrence of osteosarcoma and leprosy is exceptionally rare, presenting unique diagnostic and therapeutic challenges.
Observation:
- A 15-year-old male presented with a right knee mass, diagnosed as osteosarcoma.
- Following the first cycle of adjuvant chemotherapy (ACT), the patient developed symptoms consistent with leprosy, including fever, skin nodules, ear perichondritis, and nerve thickening.
- Slit-skin smear examination confirmed the presence of acid-fast bacilli, leading to a diagnosis of multibacillary leprosy.
Findings:
- The patient received concurrent treatment for both osteosarcoma and leprosy.
- Anti-leprosy medications and steroids were administered for leprosy, while ACT was resumed after stabilization.
- The patient achieved complete resolution of his skin lesions during follow-up.
Implications:
- This case highlights the importance of considering opportunistic infections, such as leprosy, in immunocompromised patients undergoing chemotherapy.
- It underscores the feasibility of managing co-existing malignancies and infectious diseases with a multidisciplinary approach.
- Early recognition and integrated treatment strategies are crucial for successful outcomes in patients with rare dual diagnoses.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...